Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

Substance Use Disorders Harm Reduction

Concerning reducing the harm caused by substance use disorders.
2024 Regular Session
Health Care & Health Insurance
Bill Summary

The act excludes injuries involving the possession of drugs or drug paraphernalia from a physician's mandatory reporting requirements. The act also adds an exemption to the prohibition on possessing drug paraphernalia for possession of drug paraphernalia that a person received from an approved syringe exchange program or a program carried out by a harm reduction organization while the person was participating in the program.

With respect to opioid antagonists, the act:

  • Clarifies that the civil and criminal immunity that protects a person who acts in good faith to furnish or administer an opioid antagonist also protects a person who distributes the opioid antagonist;
  • Specifies that the mere presence of an opioid antagonist is insufficient to establish probable cause to perform a warrantless search or seizure; and
  • Updates the term "opiate antagonist" to "opioid antagonist" in current law.

The act specifies that money appropriated to the department of public health and environment to purchase non-laboratory synthetic opioid detection tests may also be used to purchase other drug testing equipment.

The act authorizes an organization operating a clean syringe exchange program to:

  • Purchase and distribute other supplies and tools intended to reduce health risks associated with the use of drugs, including smoking materials; and
  • Provide drug testing services through the program.

APPROVED by Governor June 6, 2024

EFFECTIVE June 6, 2024
(Note: This summary applies to this bill as enacted.)


Became Law


Bill Text

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details